View Author
patient bortezomib myeloma dexamethasone response study therapy treatment journal neuropathy richardson trial analysis survival signi phase british journal grade blood signi ficantly response rate result cancer score high-dose dexamethasone high-dose month subgroups incidence ef ficacy bortezomib arm cycle myeloma patients baseline disease haematology bene fit research metaphase cytogenetics thalidomide england journal apex trial quality british dexamethasone arm impairment anderson table impact event summit cytogenetic ficantly progression dose modi fication publishing blackwell population jagannath blade transplantation method ficacy phase 2 study dexamethasone patients prognostic difference ficant metaphase symptom 5- week cycles fication barlogie author grade ‡2 apex study combination cell transplantation analyses dose-modi fication guideline
9 Most Recent Publications
|
Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myeloma
(Article)
Vogl, D.T. Stadtmauer, E.A. Anderson, K.C. Richardson, P.G. Sonneveld, P. Schuster, M.W. Irwin, D. Facon, T. Harousseau, J-L. Boral, A.L. Neuwirth, R. |
2009-11-01
|
|
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: Impact of a dose-modification guideline
(Article)
Richardson, P.G. Sonneveld, P. Bladé, J. Boccadoro, M. Cavenagh, J. Boral, A.L. Esseltine, D-L. Wen, P.Y. Amato, A.A. Anderson, K.C. San Miguel, J-F. Schuster, M.W. Stadtmauer, E.A. Facon, T. Harousseau, J-L. Ben-Yehuda, D. Lonial, S. Goldschmidt, H. Reece, D. |
2009-03-01
|
|
Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: Results from the APEX study
(Article)
Lee, S.J. Richardson, P.G. Anderson, K.C. Sonneveld, P. Schuster, M.W. Irwin, D. San Miguel, J-F. Crawford, B.T. Massaro, J. Dhawan, R. Gupta, S. |
2008-11-01
|
|
Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma
(Article)
Lonial, S. Richardson, P.G. Anderson, K.C. Harousseau, J-L. San Miguel, J-F. Sonneveld, P. Schuster, M.W. Bladé, J. Cavenagh, J. Rajkumar, S.V. Jakubowiak, A.J. Esseltine, D-L. |
2008-10-01
|
|
The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma
(Article)
Niesvizky, R. Richardson, P.G. Harousseau, J-L. Boral, A.L. Esseltine, D-L. Anderson, K.C. Bladé, J. Rajkumar, S.V. Coleman, M. Rosiñol, L. Sonneveld, P. Schuster, M.W. Irwin, D. Stadtmauer, E.A. Facon, T. |
2008-10-01
|
|
Efficacy and safety of bortezomib in patients with renal impairment: Results from the APEX phase 3 study
(Article)
San Miguel, J-F. Richardson, P.G. Goldschmidt, H. Reece, D. Bladé, J. Boccadoro, M. Cavenagh, J. Neuwirth, R. Boral, A.L. Esseltine, D-L. Anderson, K.C. Sonneveld, P. Schuster, M.W. Irwin, D. Stadtmauer, E.A. Facon, T. Harousseau, J-L. Ben-Yehuda, D. Lonial, S. |
2008-04-01
|
|
Extended follow-up of a phase 3 trial in relapsed multiple myeloma: Final time-to-event results of the APEX trial
(Article)
Richardson, P.G. Sonneveld, P. Reece, D. San Miguel, J-F. Bladé, J. Boccadoro, M. Cavenagh, J. Alsina, M. Rajkumar, S.V. Lacy, M. Jakubowiak, A.J. Dalton, W. Schuster, M.W. Boral, A.L. Esseltine, D-L. Schenkein, D. Anderson, K.C. Irwin, D. Stadtmauer, E.A. Facon, T. Harousseau, J-L. Ben-Yehuda, D. Lonial, S. Goldschmidt, H. |
2007-11-15
|
|
Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma
(Article)
Richardson, P.G. Sonneveld, P. Cavenagh, J. Anderson, K.C. Schuster, M.W. Irwin, D. Stadtmauer, E.A. Facon, T. Harousseau, J-L. Ben-Yehuda, D. Lonial, S. San Miguel, J-F. |
2007-06-01
|
|
Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials
(Article)
Jagannath, S. Richardson, P.G. Sonneveld, P. Schuster, M.W. Irwin, D. Stadtmauer, E.A. Facon, T. Harousseau, J-L. Cowan, J.M. Anderson, K.C. |
2007-01-01
|
